Form 4: Astrana Health Director Mitchell W. Kitayama Reports Acquisition of Restricted Stock

Director Mitchell W. Kitayama reports acquisition of 3,564 shares of Astrana Health restricted stock, vesting on the earlier of August 13, 2025, or the 2025 annual meeting.

Summary

• On August 13, 2024, Mitchell W. Kitayama, a director of Astrana Health, Inc., reported acquiring 3,564 shares of common stock.
• These shares were granted as restricted stock under the company's 2024 Equity Incentive Plan.
• The restricted shares will vest on the earlier of August 13, 2025, or the date of the Issuer's 2025 annual meeting of stockholders.
• Following the transaction, Kitayama beneficially owns 10,314 shares of Astrana Health, Inc.
• Kitayama has granted power of attorney to Brandon Sim, Chandan Basho, John Vong and Kathy Diep to handle SEC filings on his behalf.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, indicating confidence in the company's prospects. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The acquisition of restricted stock by a director signals confidence in the company's future performance.
• The vesting schedule aligns the director's interests with the long-term success of the company.

Future Outlook

The vesting of the restricted stock is tied to future dates, incentivizing the director to contribute to the company's success until at least the 2025 annual meeting.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Granting restricted stock to directors is a standard practice across the healthcare industry to incentivize long-term performance.
• Companies like UnitedHealth Group and CVS Health also utilize equity-based compensation for their directors.
• The vesting schedules are typically aligned with industry norms, ranging from one to three years.

Stakeholder Impact

• The acquisition of restricted stock by a director can positively influence shareholder confidence.
• The vesting schedule incentivizes the director to act in the best interests of the company and its stakeholders.

Key Dates